Ontology highlight
ABSTRACT: Aim
The combination of weight excess and hypertension significantly contributes to cardiovascular risk and progressive kidney damage. An unfavorable renal hemodynamic profile is thought to contribute to this increased risk and may be ameliorated by direct renin inhibition (DRI). The aim of this trial was to assess the effect of DRI on renal and systemic hemodynamics and on RAAS activity, in men with weight excess and hypertension.Methods
A randomized, double-blind, cross-over clinical trial to determine the effect of DRI (aliskiren 300 mg/day), with angiotensin converting enzyme inhibition (ACEi; ramipril 10 mg/day) as a positive control, on renal and systemic hemodynamics, and on RAAS activity (n = 15).Results
Mean (SEM) Glomerular filtration rate (101 (5) mL/min/1
SUBMITTER: Kwakernaak AJ
PROVIDER: S-EPMC5261569 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature